Algisys Raising $45 Million To Address Rising Market Demand For Food And Wellness Products Rich In Omega Ingredients.
Nov 04, 2021•almost 4 years ago
Amount Raised
$45 Million
Description
AlgiSys BioSciences, Inc. announced today that Peakstone Securities, LLC, the Axial-ranked #1 lower middle market U.S. investment bank, has been retained to raise $45 million in Series B capital to fund its initial commercial plans being driven by global customer demand for EPA omega-3 fish oil substitutes.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech